🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

View a clinical case of a full-thickness wound resulting from bilateral distal amputations due to vasopressor-induced digital ischemia. See the case study: hubs.ly/Q03t91_r0 Learn about Cohealyx™ Collagen Dermal Matrix: hubs.ly/Q03t92Tv0

AVITA Medical participated in the recent Italian Burns Society (SIUST) biennial conference in Italy. Winthrop Professor Fiona Wood, FRCS, FRACS, AM, an inventor of RECELL® Spray-On Skin™ Cells, lectured on the use of cell-based therapies to deliver strong patient outcomes.

Step into the future of wound care with PermeaDerm® Biosynthetic Wound Matrix. PermeaDerm is a next-generation primary dressing that incorporates innovative wound healing technology via a 3D microsupport system with biocoating. Get started today: bit.ly/3XQAiSR

Jeffrey E. Carter, MD, FACS, FABA, presented a case study featuring outcomes of a patient's facial burn treated with RECELL® Spray-On Skin™ Cells to stimulate healing and repigmentation throughout the wound bed. Watch it now: hubs.ly/Q03vrfJW0

Happy Fourth of July! Stay safe this holiday with a few simple tips: -Keep fireworks away from children -Have water or a fire extinguisher nearby -Use sparklers with supervision (they burn at 2,000°F!) -Never relight a “dud” firework

The AVITA Medical team was proud to attend the 2025 Phoenix Society for Burn Survivors RISE Event alongside RISE award recipient Cindy Rutter, RN, BSN, LMFT, for her dedication to the burn community. #healthcare #burn #burnwound

AVITA Medical is proud to have PermeaDerm® highlighted in this year's Western Pediatric Trauma Conference, where important insights into pediatric wound care using the biosynthetic wound matrix will be shared. Discover how PermeaDerm supports healing in young patients!

A new insights article explores targeted solutions to optimize patient recovery through modern burn care approaches and impact to patient care. Read it now: hubs.ly/Q03wsW7x0

Jeffrey E. Carter, MD, FACS, FABA, presented "The Clinical Impact of Skin Cell Suspension Autograft from a National Registry Perspective" at the 2025 BBA Annual Conference, revealing reduced length of hospital stay among burn patients treated with RECELL®. bit.ly/4enXH4O

AVITA Medical participated in the recent Plastic Surgery Congress in Sydney, Australia. Winthrop Professor Fiona Wood, FRCS, FRACS, AM, an inventor of RECELL Spray-On Skin™ Cells, delivered an educational lecture on the use of cell-based therapies in skin repair.

The future of acute wound care is here! View a clinical case of a 440cm2 full-thickness wound resulting from surgical excision. Cohealyx™ collagen dermal matrix was applied, followed by meshed autograft and RECELL® Spray-On Skin™ Cells. hubs.ly/Q03x5w120

International healthcare professionals are invited to attend a webinar with Anjay Khandelwal, MD, FACS, FICS, as he discusses RECELL Spray-On Skin™ Cells for pediatric and vulnerable populations. Register: hubs.ly/Q03x6R5T0 Content is approved for International use only.

Sharon Grason, PhD, RN, writes about the importance of reducing wound healing time using a two-stage approach in her latest article on enhancing traumatic wound management. Read the full article here: hubs.ly/Q03xt3JK0

Join us from July 22-23, 2025 at IDGA’s VA Healthcare conference in Arlington, VA along with 500+ senior leaders, clinicians, nurses, administrators, and technology professionals from across the veterans' healthcare sector. #VAhealthcare #Veterans

When it's time to graft, it's time to consider RECELL® Spray-On Skin™ Cells. RECELL technology accelerates healing at the cellular level and reduces donor skin requirements.

A peer-reviewed, head-to-head pre-clinical study demonstrated favorable performance by Cohealyx™ collagen dermal matrix across key outcomes. See how Cohealyx stands out: hubs.ly/Q03y3z020

In a recent clinical case series describing the first patient use, Cohealyx™ demonstrated wound bed readiness in as little as five to ten days. Read more on this clinical case: hubs.ly/Q03y3GvD0

PermeaDerm® biosynthetic wound matrix is a next-generation surgical dressing with multiple features that benefit clinicians, patients, and facilities. Clinicians adopt it into their standard of care for its ease of use, single application, and customizable moisture management.

Healthcare professional education is one of our top priorities. If your team would like to participate in a cadaver lab or hands-on learning workshop about our acute wound care solutions, reach out to your local sales representative.

View a case study in which PermeaDerm® was applied to a surgical wound prior to autografting. The surgical team opted for PermeaDerm over an allograft due to its cost-effectiveness, flexibility, and transparency. hubs.ly/Q03BmjtX0